EL

🌎 The company is undergoing a major restructuring, delegating profit and loss management responsibilities to regions and achieving significant cost savings, which could lead to a much faster and more significant return to profitability than expected.

Growth will be driven by several key factors: entering new markets through platforms like Amazon and Tmall, supported by AI-powered personalization; active expansion in Latin America and Southeast Asia; and an increased share of direct sales, which increases average order value and customer loyalty. Furthermore, growing demand for premium health and skincare products is fueling the company's broad portfolio of science-based products.

According to an optimistic scenario, revenue could reach $16.8 billion and net profit $1.6 billion by 2028.

In June, the downward trend was broken.
The market believes in the company's strategy, and the $85 level is holding up well for now.

Around $100, the stock needs to be closely monitored.

Until the market sees real changes in the company's performance based on the new strategy, the stock will have a hard time breaking resistance.